Last update :
26/09/2023
References   References 2113  
Type : Journal
Web link : http://springerlink.metapress.com/content/rh74033240673268/?p=e49f94994eca43c887197faa841dfc27&pi=6

Research teams : Kuopio - Kuopio University Hospital
Authors : Jäppinen A, Kokki H, Naaranlahti TJ, Rasi AS.
Title : Stability of buprenorphine, haloperidol and glycopyrrolate mixture in a 0.9% sodium chloride solution.
Reference : Pharm World Sci ; 21, 6: 272-274. 1999

Level of Evidence : 
Physical stability : 
Chemical stability : 
Other methods : 
Comments : 

List of drugs
InjectionBuprenorphine hydrochloride Analgesic
InjectionGlycopyrronium bromide Antimuscarinic
InjectionHaloperidol lactate Neuroleptic
Stability of mixtures
Polyvinyl chloride Sodium chloride 0,9% 21°C Protect from light
Injection Glycopyrronium bromide 15 mg/ml
Injection Haloperidol lactate 52 mg/ml
Injection Buprenorphine hydrochloride 57 mg/ml
30 Day
Polyvinyl chloride Sodium chloride 0,9% 36°C Protect from light
Injection Glycopyrronium bromide 15 mg/ml
Injection Haloperidol lactate 52 mg/ml
Injection Buprenorphine hydrochloride 57 mg/ml
9 Day
Polyvinyl chloride Sodium chloride 0,9% 4°C Protect from light
Injection Glycopyrronium bromide 15 mg/ml
Injection Haloperidol lactate 52 mg/ml
Injection Buprenorphine hydrochloride 57 mg/ml
30 Day
Polypropylene Sodium chloride 0,9% 21°C Protect from light
Injection Glycopyrronium bromide 15 mg/ml
Injection Haloperidol lactate 52 mg/ml
Injection Buprenorphine hydrochloride 57 mg/ml
30 Day
Polypropylene Sodium chloride 0,9% 36°C Protect from light
Injection Glycopyrronium bromide 15 mg/ml
Injection Haloperidol lactate 52 mg/ml
Injection Buprenorphine hydrochloride 57 mg/ml
16 Day
Polypropylene Sodium chloride 0,9% 4°C Protect from light
Injection Glycopyrronium bromide 15 mg/ml
Injection Haloperidol lactate 52 mg/ml
Injection Buprenorphine hydrochloride 57 mg/ml
30 Day

  Mentions Légales